Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future DirectionsOA
Advances in Cellular Immune Theranostic Approaches for Glioblastoma:Current Trends and Future Directions
Ying Gong;Zhiyan Piao;Siping Wu;Junhao Li;ZongZhong He;Haixia Li;Hongxia Wang;Wanying Lin;Xuechun Fang;Ruyi Zhang;Min Luo;Haoran Wu;Shuai Chu;Chuangkun Li;Yiming Peng
Department of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaGuangdong Provincial Clinical Research Center for Laboratory Medicine,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Internal Medicine,Division of Hematology,University of Maastricht,Maastricht,the NetherlandsDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Transfusion Medicine of General Hospital of Southern Theatre Command,Guangdong,Guangzhou,ChinaDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaGuangdong Provincial Clinical Research Center for Laboratory Medicine,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaGuangdong Provincial Clinical Research Center for Laboratory Medicine,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaGuangdong Provincial Clinical Research Center for Laboratory Medicine,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaDepartment of Laboratory Medicine,Guangdong Provincial Key Laboratory of Precision Medical Diagnostics,Guangdong Provincial Key Laboratory of Single-cell and Extracellular Vesicles,Guangdong Engineering and Technology Research Center for Rapid Diagnostic Biosensors,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,ChinaGuangdong Provincial Clinical Research Center for Laboratory Medicine,Nanfang Hospital,Southern Medical University,Guangdong,Guangzhou,China
CAR-T therapycheckpoint inhibitorglioblastomaimmunotherapytumor microenvironment
CAR-T therapycheckpoint inhibitorglioblastomaimmunotherapytumor microenvironment
《肿瘤学创新（英文）》 2025 (4)
59-81,23
This study was supported by the National Natural Science Foundation of China(82004105,82002218,and 82202978),President's Fund of Nanfang Hospital,Southern Medical University(2022B041 and 2024B031),and the Outstanding Youths Development Scheme of Nanfang Hospital,Southern Medical University(2024J007).
评论